你即將離開本站

並前往https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30747-8/fulltext

Ceftazidime-avibactam versus meropenem in ... - The Lancet

REPROVE was a prospective, international, multicentre, parallel-group, randomised, double-blind, double-dummy, phase 3 non-inferiority trial.

確定！ 回上一頁

查詢 「Reprove」的人也找了：

  1. Scold
    2.
  2. Reprobate
    3.
  3. Admonish
    4.
  4. Rebuke
    5.
  5. Assuage
    6.
  6. Repudiate
    7.
  7. Repugnant
    8.
  8. Prove
    9.